SCL Science Inc. (KOSDAQ:246960)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,300.00
0.00 (0.00%)
At close: Oct 23, 2026

SCL Science Revenue

SCL Science had revenue of 7.59B KRW in the quarter ending June 30, 2026, with 68.91% growth. This brings the company's total for the last twelve months to 30.50B, up 194.27% year-over-year. In the year 2025, SCL Science had annual revenue of 22.01B with 364.64% growth. That makes SCL Science the 32,948th largest company in the world by revenue and 2,105th in South Korea.

Revenue (ttm)
30.50B
Revenue Growth
+194.27%
P/S Ratio
2.57
Revenue / Employee
190.63M
Employees
160
Market Cap
78.23B

Revenue Chart

Revenue by Geography

  • Korea 21.91B 99.6%
  • United States of America 88.59M 0.4%
  • Japan 4.74M 0.0%
  • Hong Kong 4.23M 0.0%
Fiscal year ended Dec 31, 2025 See the full SCL Science breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202522.01B17.27B364.64%
Dec 31, 20244.74B3.42B258.30%
Dec 31, 20231.32B952.33M257.54%
Dec 31, 2022369.78M-137.51M-27.11%
Dec 31, 2021507.29M-88.90M-14.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
KM Corporation144.10B
JW Shinyak81.04B
Sewoon Medical66.53B
CG MedTech51.20B
OSTEONIC50.97B
DuChemBIO41.51B
Wonbiogen37.80B
Plasmapp12.02B
Revenue Rankings